Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly T Beinfeld

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Radiology|April 19, 2005
Diagnostic imaging costs: are they driving up the costs of hospital care?Molly T Beinfeld, G Scott Gazelle
Radiology|January 27, 2005
Cost-effectiveness of whole-body CT screeningMolly T Beinfeld, Eve Wittenberg, G Scott Gazelle
Academic Radiology|November 27, 2002
Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumorsMolly T Beinfeld, Johanna L Bosch, G Scott Gazelle
Clinical Therapeutics|July 22, 2024
Balancing Evidence and Need: Variation in US Commercial Payer Coverage of EsketamineEkwu B Ochigbo, Molly T Beinfeld, James D Chambers
Journal of Managed Care & Specialty Pharmacy|April 3, 2025
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edemaJames D Chambers, Molly T Beinfeld, Terry Richardson, et al.
Radiology|April 29, 2005
Cost-effectiveness analysis in the assessment of diagnostic imaging technologiesG Scott Gazelle, Pamela M McMahon, Uwe Siebert, et al.
Radiology|December 26, 2003
Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroidsMolly T Beinfeld, Johanna L Bosch, Keith B Isaacson, et al.
Health Affairs Scholar|July 29, 2024
Biosimilar underutilization alone does not foretell a broken biologics marketFariel LaMountain, Molly T Beinfeld, William Wong, et al.
Health Affairs (Project Hope)|September 3, 2024
US Commercial Plans Increase Choice Of Biosimilar And Originator Products; Market Net Prices DecreaseMolly T Beinfeld, Fariel LaMountain, William Wong, et al.
The American Journal of Cardiology|September 5, 2006
Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency departmentUwe Siebert, James L Januzzi, Molly T Beinfeld, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Radiology|April 19, 2005
Diagnostic imaging costs: are they driving up the costs of hospital care?Molly T Beinfeld, G Scott Gazelle
Radiology|January 27, 2005
Cost-effectiveness of whole-body CT screeningMolly T Beinfeld, Eve Wittenberg, G Scott Gazelle
Academic Radiology|November 27, 2002
Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumorsMolly T Beinfeld, Johanna L Bosch, G Scott Gazelle
Clinical Therapeutics|July 22, 2024
Balancing Evidence and Need: Variation in US Commercial Payer Coverage of EsketamineEkwu B Ochigbo, Molly T Beinfeld, James D Chambers
Journal of Managed Care & Specialty Pharmacy|April 3, 2025
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edemaJames D Chambers, Molly T Beinfeld, Terry Richardson, et al.
Radiology|April 29, 2005
Cost-effectiveness analysis in the assessment of diagnostic imaging technologiesG Scott Gazelle, Pamela M McMahon, Uwe Siebert, et al.
Radiology|December 26, 2003
Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroidsMolly T Beinfeld, Johanna L Bosch, Keith B Isaacson, et al.
Health Affairs Scholar|July 29, 2024
Biosimilar underutilization alone does not foretell a broken biologics marketFariel LaMountain, Molly T Beinfeld, William Wong, et al.
Health Affairs (Project Hope)|September 3, 2024
US Commercial Plans Increase Choice Of Biosimilar And Originator Products; Market Net Prices DecreaseMolly T Beinfeld, Fariel LaMountain, William Wong, et al.
The American Journal of Cardiology|September 5, 2006
Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency departmentUwe Siebert, James L Januzzi, Molly T Beinfeld, et al.
Pageof 3